Feasibility and Short-Term Outcomes of Percutaneous Transcatheter Pulmonary Valve Replacement in Small ( | Zendy

Darren P. Berman | Zendy; Doff B. McElhinney | Zendy; Julie A. Vincent | Zendy; William E. Hellenbrand | Zendy; Evan M. Zahn | Zendy

Open Access

Feasibility and Short-Term Outcomes of Percutaneous Transcatheter Pulmonary Valve Replacement in Small (<30 kg) Children With Dysfunctional Right Ventricular Outflow Tract Conduits

Author(s) -

Darren P. Berman,

Doff B. McElhinney,

Julie A. Vincent,

William E. Hellenbrand,

Evan M. Zahn

Publication year - 2014

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.113.000881

Subject(s) - medicine , ventricular outflow tract , surgery , implant , electrical conduit , stenosis , stent , regurgitation (circulation) , percutaneous , endocarditis , cardiology , mechanical engineering , engineering

In 2010, the Melody transcatheter pulmonary valve (TPV) received Food and Drug Administration approval for treatment of dysfunctional right ventricular outflow tract conduits in patients ≥30 kg. Limited data are available regarding use of this device in smaller patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research